Apexigen logo

Apexigen

Creating Transformative Immunotherapies for Patients with Cancer

11 employees · est. 2010 · San Carlos, United States

VS
NEOGAP Therapeutics AB logo

NEOGAP Therapeutics AB

Science for cure.

28 employees · est. 2016 · Stockholm, Sweden

Apexigen is the older company (2010 vs 2016).

Side-by-Side Comparison

Apexigen NEOGAP Therapeutics AB
Founded
2010 older 2016
Headquarters
San Carlos, United States Stockholm, Sweden
Employees
11 28
Industry
Biopharma, Biotechnology, Health Care Biotechnology, Health Care, Pharmaceutical
Funding Stage
Post Ipo Equity Grant
Total Funding
$175.80M $147.66M
Funding Rounds
6 5
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharmaceutical Company, Clinical-stage, Antibody Therapeutics, Immunotherapy, Cancer Treatment, Immuno-oncology, Sotigalimab, Phase 2 Clinical Development, Immune-activating Antibody, CD40, Cancer Immunotherapy, Oncology Drug Candidate Biopharmaceutical, Immunotherapy, Cancer Treatment, Clinical-stage Company, Cancer Immunotherapy, Immuno-oncology, Tumor-specific Responses, Personalized Cell Treatment, Clinical Stage Biopharmaceutical, Cancer Research, Precision Medicine, Innovative Therapy, Karolinska Institute, Stockholm, Sweden, Therapeutic Immune Design
Website
apexigen.com neogap.se
Apexigen logo

About Apexigen

Apexigen is a clinical-stage biopharmaceutical company founded in 2010 with a focus on creating transformative immunotherapies for patients with cancer. The company is dedicated to discovering and developing a new generation of antibody therapeutics for the treatment of cancer, particularly emphasiz...

NEOGAP Therapeutics AB logo

About NEOGAP Therapeutics AB

NEOGAP Therapeutics AB is a privately held clinical stage biopharmaceutical company with the main focus on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund. We are located at Therapeutic Immune Design, Centre for Molecular Medicine at Karolinska Institute, Stockholm, Sweden. Ou...

We will tell you when either one moves

BounceWatch watches Apexigen and NEOGAP Therapeutics AB for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Apexigen and NEOGAP Therapeutics AB — by email.

Frequently Asked Questions

Apexigen — Creating Transformative Immunotherapies for Patients with Cancer . NEOGAP Therapeutics AB — Science for cure. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Apexigen has raised $175.80M while NEOGAP Therapeutics AB has raised $147.66M.
Apexigen and NEOGAP Therapeutics AB operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Apexigen with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Apexigen on 12 Sep 2024, and NEOGAP Therapeutics AB on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy